Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 40507

Decrease in Oxidatively Modified LDL during Long- term LDL-Apheresis Treatment


Mrzljak, Vladimir; Turk, Zdenka; Pavković, Pajica; Metelko, Željko
Decrease in Oxidatively Modified LDL during Long- term LDL-Apheresis Treatment // Abstracts of the 17th International Diabetes Federation Congress ; u: Diabetes Research & Clinical Practise 50 (2000) (S1) ; 1-474 ; P1258 / Cockram, C. S. (ur.).
Shannon, Irska: Elsevier, 2000. str. S312-S312 (poster, međunarodna recenzija, sažetak, znanstveni)


CROSBI ID: 40507 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Decrease in Oxidatively Modified LDL during Long- term LDL-Apheresis Treatment

Autori
Mrzljak, Vladimir ; Turk, Zdenka ; Pavković, Pajica ; Metelko, Željko

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni

Izvornik
Abstracts of the 17th International Diabetes Federation Congress ; u: Diabetes Research & Clinical Practise 50 (2000) (S1) ; 1-474 ; P1258 / Cockram, C. S. - Shannon, Irska : Elsevier, 2000, S312-S312

Skup
International Diabetes Federation Congress (17 ; 2000)

Mjesto i datum
Mexico City, Meksiko, 05.-10.11.2000

Vrsta sudjelovanja
Poster

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
Hyperlipemia; LDL-apheresis; Oxidized-LDL

Sažetak
The aim of the present study was to follow-up generation of autoantibodies against oxidatively modified LDL in a patient suffering from severe combined hyperlipidemia during long-term LDL apheresis alone or in combination with statin therapy. An ELISA using MDA-LDL as coating antigen measured anti-oxLDL titre. Baseline value of 82.8 2.1 U/ml was reduced only for 7.8% after 2-month of statin therapy, and decrease of 10.7% was achieved by LDL-apheresis treatment. Long-term LDL-apheresis combined with statin was more effective. Multiple comparison among the four 6-month periods showed significant reduction of mean values in II and III semester (58.0 13.8 vs 37.6 6.0 U/ml, p<0.00053) of the treatment. In parallel to the changes in this biochemical parameter, regression of numerous xanthomas was clinically observed. In spite of this, the presence of ox-LDL antibodies was enhanced in comparison to antibody titer detected in a group of age-matched normolipemic controls (n=15 ; 19.4 8.6 ; p<0.01). The significant reduction of baseline total cholesterol (58%), total triglycerides (80%), LDL cholesterol (48%), apoprotein B (50%) and apolipoprotein (a) (61%) may be considered as a good response to the treatment. LDL/HDL cholesterol ratio, an index of atherosclerosis, was significantly reduced from 13.0 to 2.6. Classical lipoprotein parameters showed low correlation coefficients with anti-oxLDL titer. The reason may lie in the possibility that the primary location of the analyzed parameter is not in the circulation. The production of autoantibodies against oxLDL was reduced during LDL-apheresis, indicating a lower level of the atherogenic antigen. The study showed an additional benefit of LDL-apheresis treatment.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti

Napomena
Http://dx.doi.org/10.1016/S0168-8227(00)81064-5 ; DOI: 10.1016/S0168-8227(00)81064-5



POVEZANOST RADA


Projekti:
045003

Ustanove:
Klinika za dijabetes, endokrinologiju i bolesti metabolizma Vuk Vrhovac

Profili:

Avatar Url Pajica Pavković (autor)

Avatar Url Vladimir Mrzljak (autor)

Avatar Url Željko Metelko (autor)

Avatar Url Zdenka Turk (autor)

Citiraj ovu publikaciju:

Mrzljak, Vladimir; Turk, Zdenka; Pavković, Pajica; Metelko, Željko
Decrease in Oxidatively Modified LDL during Long- term LDL-Apheresis Treatment // Abstracts of the 17th International Diabetes Federation Congress ; u: Diabetes Research & Clinical Practise 50 (2000) (S1) ; 1-474 ; P1258 / Cockram, C. S. (ur.).
Shannon, Irska: Elsevier, 2000. str. S312-S312 (poster, međunarodna recenzija, sažetak, znanstveni)
Mrzljak, V., Turk, Z., Pavković, P. & Metelko, Ž. (2000) Decrease in Oxidatively Modified LDL during Long- term LDL-Apheresis Treatment. U: Cockram, C. (ur.)Abstracts of the 17th International Diabetes Federation Congress ; u: Diabetes Research & Clinical Practise 50 (2000) (S1) ; 1-474 ; P1258.
@article{article, author = {Mrzljak, Vladimir and Turk, Zdenka and Pavkovi\'{c}, Pajica and Metelko, \v{Z}eljko}, editor = {Cockram, C.}, year = {2000}, pages = {S312-S312}, keywords = {Hyperlipemia, LDL-apheresis, Oxidized-LDL}, title = {Decrease in Oxidatively Modified LDL during Long- term LDL-Apheresis Treatment}, keyword = {Hyperlipemia, LDL-apheresis, Oxidized-LDL}, publisher = {Elsevier}, publisherplace = {Mexico City, Meksiko} }
@article{article, author = {Mrzljak, Vladimir and Turk, Zdenka and Pavkovi\'{c}, Pajica and Metelko, \v{Z}eljko}, editor = {Cockram, C.}, year = {2000}, pages = {S312-S312}, keywords = {Hyperlipemia, LDL-apheresis, Oxidized-LDL}, title = {Decrease in Oxidatively Modified LDL during Long- term LDL-Apheresis Treatment}, keyword = {Hyperlipemia, LDL-apheresis, Oxidized-LDL}, publisher = {Elsevier}, publisherplace = {Mexico City, Meksiko} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE





Contrast
Increase Font
Decrease Font
Dyslexic Font